Pier Giorgio Cojutti

Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients

Federico Pea, Pierluigi Viale, Pier Giorgio Cojutti et al. · Journal of Antimicrobial Chemotherapy · 2012 · 246 citations · Full text

Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis

Federico Pea, Mario Furlanut, Pier Giorgio Cojutti et al. · Antimicrobial Agents and Chemotherapy · 2010 · 188 citations · Full text

Standard Dosage, Pharmacotherapy, Adverse Drug Reaction +17

Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety

Ryan L. Crass, Pier Giorgio Cojutti, Manjunath P. Pai et al. · Antimicrobial Agents and Chemotherapy · 2019 · 109 citations · Full text

Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients

Milo Gatti, Pier Giorgio Cojutti, Michele Bartoletti et al. · Critical Care · 2022 · 95 citations · Full text

A 10‐Year Experience of Therapeutic Drug Monitoring (<scp>TDM</scp>) of Linezolid in a Hospital‐wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting <scp>TDM</scp> in the Majority of Patients?

Federico Pea, Pier Giorgio Cojutti, Massimo Baraldo · Basic & Clinical Pharmacology & Toxicology · 2017 · 87 citations · Full text